Comprehensive Outcomes for After Cancer Health
for Ovarian Cancer
7 locations incl. Gainesville
Sponsor: Pack Health
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT05349227·Recruiting
Ovarian cancer Clinical Trials in Houston, TX
As of June 2026, 60 paid clinical trials are recruiting for Ovarian cancer in Houston, Texas. Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Houston
Filter results
Filter results
60 clinical trials for Ovarian cancer
·Clear filters·↓ Download CSVRisk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
for Ovarian Cancer
9 locations incl. Boston
Sponsor: M.D. Anderson Cancer Center
Sex: Female·Age: 18+
Code: NCT05287451·Recruiting
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
for Ovarian Cancer
1 location in Houston
Sponsor: M.D. Anderson Cancer Center
Sex: Female·Age: 18+
Code: NCT05123807·Phase 2·Recruiting
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
for Colorectal Carcinoma
21 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: 12 Months - 30
Code: NCT04851119·Phase 1, Phase 2·Recruiting
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
for Solid Tumor, Adult
16 locations incl. Gilbert
Sponsor: A2 Biotherapeutics Inc.
Sex: All·Age: 18+
Code: NCT04981119·Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
for Breast Cancer
14 locations incl. Duarte
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT05123482·Phase 1, Phase 2·Recruiting
A Beta-only IL-2 ImmunoTherapY Study
for Advanced Solid Tumor
7 locations incl. San Diego
Sponsor: Medicenna Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05086692·Phase 1, Phase 2·Recruiting
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
for Endometrial Cancer
24 locations incl. Phoenix
Sponsor: Mayo Clinic
Sex: Female·Age: 18+
Code: NCT05051722·Recruiting
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
for Salivary Gland Tumor
Drug: AVA6000
3 locations incl. New York
Sponsor: Avacta Life Sciences Ltd
Sex: All·Age: 18+
Code: NCT04969835·Phase 1·Recruiting
A Study of Intra-operative Imaging in Women With Ovarian Cancer
for Ovarian Cancer
9 locations incl. Basking Ridge
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female·Age: All ages
Code: NCT04878094·Phase 3·Recruiting
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
for Colitis
1 location in Houston
Sponsor: M.D. Anderson Cancer Center
Sex: All·Age: 18+
Code: NCT04038619·Phase 1·Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
for Advanced Cancer
40 locations incl. Birmingham
Sponsor: Artios Pharma Ltd
Sex: All·Age: 18+
Code: NCT04657068·Phase 1, Phase 2·Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
for Advanced Solid Tumor
32 locations incl. Irvine
Sponsor: PMV Pharmaceuticals, Inc
Sex: All·Age: 12+
Code: NCT04585750·Phase 1, Phase 2·Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for Ovarian Carcinoma
539 locations incl. Birmingham
Sponsor: NRG Oncology
Sex: Female·Age: 35 - 50
Code: NCT04251052·Recruiting
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
for Advanced Malignant Neoplasm
4 locations incl. Los Angeles
Sponsor: AtlasMedx, Incorporated
Sex: All·Age: 18+
Code: NCT04503265·Phase 1, Phase 2·Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
for BRCA1 Gene Mutation
11 locations incl. Chicago
Sponsor: University Medical Center Nijmegen
Sex: Female·Age: 25 - 50
Code: NCT04294927·Recruiting
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
for Breast Carcinoma
1 location in Houston
Sponsor: M.D. Anderson Cancer Center
Sex: Female·Age: 18+
Code: NCT03604315·Phase 1·Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for Cancer, Metastatic
67 locations incl. Birmingham
Sponsor: Massive Bio, Inc.
Sex: All·Age: All ages
Code: NCT03452774·Recruiting
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
for Low Grade Ovarian Serous Adenocarcinoma
1 location in Houston
Sponsor: M.D. Anderson Cancer Center
Sex: Female·Age: All ages
Code: NCT00488878·Recruiting
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
for Ovarian Cancer
12 locations incl. Miami
Sponsor: M.D. Anderson Cancer Center
Sex: Female·Age: 50 - 74·Accepts healthy volunteers
Code: NCT00539162·Recruiting